# Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters

> **NCT00157651** · PHASE3 · COMPLETED · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 170 (actual)

## Conditions studied

- End Stage Renal Disease
- Thrombosis
- Bleeding

## Interventions

- **DRUG:** warfarin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00157651
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-02
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2008-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00157651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00157651, "Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00157651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*